RESEARCH ARTICLE


Is the Patient Getting Worse?



Singh Kuldev*
Glaucoma Service, Stanford University, USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 835
Abstract HTML Views: 714
PDF Downloads: 177
Total Views/Downloads: 1726
Unique Statistics:

Full-Text HTML Views: 511
Abstract HTML Views: 441
PDF Downloads: 120
Total Views/Downloads: 1072



© Kuldev Singh; Licensee Bentham Open.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Glaucoma Service, Stanford University, USA; E-mail: kuldev.singh@stanford.edu


Abstract

Glaucoma care today is often simplified into all or nothing terms with the assumption that if the patient’s intraocular pressure (IOP) is above a certain level, glaucomatous disease will progress and when the IOP is lowered to below a threshold, no further progression will occur. This dogma is largely the result of limitations in the resolution of tools currently available to judge progression. Glaucoma is a neurodegenerative disease and, as with all degenerative diseases, progression continues to occur, albeit at slower rates, with appropriate treatment. In the future, as our tools to assess structural and functional optic nerve change become more precise, we will no longer think of glaucoma as being stable or progressive but rather speak in terms of rates of progression.